Literature DB >> 35256568

Vulvovaginal Pyoderma Gangrenosum in a Patient Treated With Ocrelizumab for Multiple Sclerosis.

Alyssa N Breneman1, Ariel E Eber2, Hoosna Haque3, Libby Levine4, Anca Askanase5, Claire S Riley4, Miriam Keltz Pomeranz6, Dahlia Hassan5, Silvia E Mancebo7, Melanie Polin8, Alexander Melamed9, Lindsey A Bordone2, Mary Rosser3, Allison Gockley9, Stephanie M Gallitano2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35256568     DOI: 10.1097/LGT.0000000000000661

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


× No keyword cloud information.
  1 in total

1.  Ocrelizumab-induced vulvovaginal pyoderma gangrenosum in a patient with relapsing-remitting multiple sclerosis.

Authors:  Annika Klumpp; Felix Luessi; Sinah Engel; Beate Weidenthaler-Barth; Detlef Becker; Stephan Grabbe; Hadrian Schepler
Journal:  JAAD Case Rep       Date:  2022-08-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.